Infantile hypertrophic cardiomyopathy associated with a novel MYL3 mutation

Cardiology (Switzerland)

Volumn 124, Issue 4, 2013, Pages 248-251

  Jay, Allison ^a   Chikarmane, Rashmi ^a   Poulik, Janet ^b   Misra, Vinod K ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Childhood onset cardiomyopathy; Hypertrophic cardiomyopathy; Myosin light chain; Sarcomeric mutation

Indexed keywords

ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; EXON; EXTRACORPOREAL OXYGENATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; HYPOKINESIA; INFANT; LEFT VENTRICULAR ASSIST DEVICE; MALE; MISSENSE MUTATION; MYL3 GENE; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; GENE; MYOSIN LIGHT CHAIN 3 GENE;

CARDIOMYOPATHY, HYPERTROPHIC; FATAL OUTCOME; HUMANS; INFANT; MALE; MUTATION; MYOSIN LIGHT CHAINS;

MYOSIN;

EID: 84876080366     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000347138     Document Type: Article

References (12)

1. Richard P, Villard E, Charron P, Isnard R: The genetic bases of cardiomyopathies. J Am Coll Cardiol 2006; 48:A79-A89.
2. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA: Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the pediatric cardiomyopathy registry. Circulation 2007; 115: 773-781.
3. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III., Spirito PTen Cate FJ, Wigle ED; Task Force on Clinical Expert Consensus Documents, American College of Cardiology; Committee for Practice Guidelines, European Society of Cardiology: American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42: 1687-1713.
4. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG; National Australian Childhood Cardiomyopathy Study: Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 2005; 112: 1332-1338.
5. Kaski JP, Syrris P, Esteban MT, Jenkins S, Pantazis A, Deanfield JE, McKenna WJ, Elliott PM: Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2009; 2: 436-441.
6. Morita H,Rehm HL,Menesses A,McDonough B,Roberts AE,Kucherlapati R,Towbin JA,Seidman JG,Seidman CE. Shared genetic causes of cardiac hypertrophy in children and adults N Engl J Med 2008; 358:1899-1908.
7. Lossie J, Ushakov DS, Ferenczi MA, Werner S, Keller S, Haase H, Morano I: Mutations of ventricular essential myosin light chain disturb myosin binding and sarcomeric sorting. Cardiovasc Res 2012; 93: 390-396.
8. Hernandez OM, Jones M, Guzman G, Szczesna- Cordary D: Myosin essential light chain in health and disease. Am J Physiol Heart Circ Physiol 2007; 292:H1643-H1654.
9. Lee MS, Macrae CA: Revisiting risk stratification in hypertrophic cardiomyopathy: do we need to start from scratch Heart Rhythm 2012; 9: 64-65.
10. Machin GA: Some causes of genotypic and phenotypic discordance in monozygotic twin pairs. Am J Med Genet 1996; 61: 216-228.
11. Olson TM, Karst ML, Whitby FG, Driscoll DJ: Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology. Circulation 2002; 105: 2337-2340.
12. Harris SP, Lyons RG, Bezold KL: In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res 2011; 108: 751-764.